Following the shortened Thanksgiving week here in the states, there's potentially only one IPO that could launch. As the year nears its end, the clock is ticking for any names that would like to launch before 2019. Given the recent market declines and volatility, many names have simply postponed or have yet to file. There are potentially five names that could launch this week, though almost everyone expects only one to take the plunge.
Last week there were two names that did end up launching, raising just under $25 million between them. TuanChe (NYSE: TC), an auto show event organizer, raised $20 million, pricing at the lower end of their range, and Taiwan Liposome Co. (NYSE: TLC), a small biotech company, raised $22 million but priced below their target offering.
The names that could schedule their IPO this week but have yet to confirm include the Uranium Trading Corp. (NYSE: UTC is its proposed signal), a new company formed this year that's hoping to provide a vehicle to investors looking for investment opportunities in the uranium markets. Though they have no revenue or sales yet, they're looking to raise $50 million. To do this they will offer 4.5 million shares at a range of $10 -$12, which would give them a valuation of around $54 million. Other names that will be eligible include biotech companies Moderna (NASDAQ: MRNA), Synthorx (NASDAQ: THOR), and DiaMedica Therapeutics (NASDAQ: DMAC), as well as prefab home maker Legacy Housing (NASDAQ: LEGH) and fuel company New Fortress Energy (NASDAQ: NFE).